The BAC transgene Tbx5CreERT2 was constructed from the BAC clone RP23-267B1570 (link) by replacement of exon 2 of Tbx5 with a CreERT2 cassette at the first methionine of the open reading frame in EL250 cells23 (link),71 (link). The BAC-Tbx5CreERT2 transgenes were crossed with Rosa26ReYFP/eYFP transgenic mice (B6.129×1-Gt(ROSA)26Sortm1(EYFP)Cos/J) from Jackson laboratories stock# 006148, in order to produce Tbx5CreERT2/Rosa26ReYFP/eYFP mice employed in this study. The Tbx5CreERT2/+/Rosa26ReYFP/+/Rosa26RiDTR/+ was created using the tamoxifen-induced Rosa26RiDTR/iDTR transgene72 (link) (Jackson laboratories stock# 007900) provided by the Klinakis lab (BRFAA).
All animal work has been approved by the BRFAA ethics committee and the Attica Veterinary Department (Animal Licence; 60876/23-1-20). All animals used were 2–3 months of age upon the time of ischemia/reperfusion (I/R) or isoproterenol administration experiments following relevant inclusion/exclusion guideline criteria73 (link).
Free full text: Click here